Claude did not invent scorpion antivenom
Investment research firm Citrini Research partnered with Anthropic to test whether Claude could generate a new drug from scratch, specifically scorpion antivenom. Despite publishing optimistic framing, the experiment yielded only promising starting points but no actual drug candidate. Experts confirmed Claude's output fell far short of a usable pharmaceutical product, highlighting gaps between AI capability claims and practical drug development.
Key points
- Claude could not create scorpion antivenom despite the attempt
- Generated only preliminary research directions, not functional drug
- Researchers lacked deep biology knowledge
- Illustrates gap between AI potential and practical drug development
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. The Verge did the reporting; read the original for the full story.
Read the full story at The Verge
